RESUMO

A combination of tiletamine-zolazepam, medetomidine, and azaperone was used to immobilize captive Chacoan peccaries (Catagonus wagneri) for health assessments and biological sample collection at the Centro Chaqueño para la Conservación e Investigación (CCCI) in the Paraguayan Chaco during July in 2017 and 2018. In total, 83 peccaries kept in 0.25-1.50 hectare enclosures were immobilized via dart-administered anesthetic. Mean animal weight was 33.89±3.74 kg (standard deviation; n=77). The mean intramuscular (IM) anesthetic drug and dosages were 0.03±0.00 mg/kg of medetomidine, 0.91±0.10 mg/kg of Zoletil 50 (tiletamine-zolazepam), and 0.30±0.03 mg/kg azaperone. The mean time to recumbency after darting was 6.07±2.65 min. The mean time to reach the anesthetic plane postdarting was 10.00±2.00 min. Muscle relaxation was adequate to allow minor veterinary procedures. A mean dosage of 0.15±0.02 mg/kg of atipamezole was given IM to reverse the medetomidine. Recoveries were smooth and animals were standing by 59.17±30.18 min postreversal. Full recovery and release back to enclosures occurred 90±30 min postreversal. A single dose of this drug combination provided adequate anesthesia for 88% of adult Chacoan peccaries; 12% needed a supplemental dose of tiletamine-zolazepam because of failure to receive the full dose from the anesthetic dart. Sex and age did not impact the dosage required to achieve immobilization. Confinement during recovery from anesthesia is required with this protocol. Aside from mild hypoxemia, no adverse effects from anesthesia were observed. However, oxygen supplementation as a part of this protocol is recommended to support circulatory and respiratory capacity.

Assuntos

RESUMO

Fifteen maned wolves (Chrysocyon brachyurus) were anesthetized a total of 43 times as part of a long-term ecology and health study in a remote region of northeastern Bolivia. We administered tiletamine-zolazepam (TZ) to wolves in box traps or free-ranging, from blinds or on foot, at a mean dosage of 4.6 mg/kg intramuscularly. Detailed anesthetic information was recorded in 24 of these events in 11 wolves (six males, five females), and wolves were monitored closely post procedure with very high frequency or global positioning system telemetry collars. Anesthetic induction was smooth and rapid in all cases, with a mean 6.4 min from injection to recumbency. Vital parameters were stable during the majority of procedures. As expected with this drug combination, recovery was long (mean time to standing 163 min [range: 80-235 min]) but smooth, and animals were monitored in most cases in box traps until stable for release. One case of apnea and prolonged recovery is reported. In two cases, wolves recovered normally but were found to move minimally in the 2.5-4 d postprocedure before resuming normal movements. Overall, TZ provided safe, stable immobilization of free-ranging maned wolves in remote and extreme field conditions, although postanesthesia monitoring via telemetry is recommended.

Assuntos

RESUMO

OBJECTIVES: The aim of this study was to describe the sedative and some physiological effects of tiletamine-zolazepam following buccal administration (BA) in cats. METHODS: Seven healthy spayed European shorthair cats (three males, four females) were studied twice in this randomized, blinded, crossover study. Each cat received two doses of tiletamine-zolazepam by BA: the low-dose (LD) group consisted of 5 mg/kg of each drug, and the high-dose (HD) group consisted of 7.5 mg/kg of each. Baseline systolic blood pressure (SAP), heart rate (HR), respiratory rate (RR) and a sedation score were recorded prior to administration of each treatment. The same variables plus the percentage of hemoglobin saturated with oxygen as measured by pulse oximetry (SpO2) were recorded at predefined intervals for the next 2 h. RESULTS: All cats completed the study. No retching or vomiting were observed. Hypersalivation was observed in 0/7 and 3/7 for LD and HD groups, respectively (P = 0.2). There were significant changes in scores over time for posture, response to clippers and response to manual restraint for both groups, without differences between groups. RR, HR and SAP changed significantly over time. SAP and RR were significantly lower for the HD than for the LD group. No values for hemoglobin saturation <95% were observed. CONCLUSIONS AND RELEVANCE: BA of tiletamine-zolazepam at the doses studied here is a simple and effective method for chemical restraint in cats, where the LD group had a lower impact on SAP and RR than the HD group.

Assuntos

RESUMO

Dissociative anesthesia results in stressful and long recovery periods in monkeys and use of injectable anesthetics in medical research has to be refined. Propofol has promoted more pleasure wake up from anesthesia. The objectives of this study were to investigate the use of intravenous anesthetic propofol, establishing the required infusion rate to maintain surgical anesthetic level and comparing it to tiletamine-zolazepam anesthesia in Sapajus apella. Eight healthy capuchin monkeys, premedicated with midazolam and meperidine, were anesthetized with propofol (PRO) or tiletamine-zolazepam (TZ) during 60 minutes. Propofol was infused continually and rate was titrated to effect and tiletamine-zolazepam was given at 5mg/kg IV bolus initially and repeated at 2.5mg/kg IV bolus as required. Cardiopulmonary parameters, arterial blood gases, cortisol, lactate and quality and times to recovery were determined. Recovery quality was superior in PRO. Ventral recumbency (PRO = 43.0±21.4 vs TZ = 219.3±139.7 min) and normal ambulation (PRO = 93±27.1 vs TZ = 493.7±47.8 min) were faster in PRO (p<0.05). Cardiopulmonary effects did not have marked differences between groups. Median for induction doses of propofol was 5.9mg/kg, varying from 4.7 to 6.7mg/kg, Mean infusion rate was 0.37±0.11mg/kg/min, varying during the one-hour period. In TZ, two animals required three and five extra doses. Compared to tiletamine-zolazepam, minor post-anesthetic adverse events should be expected with propofol anesthesia due to the faster and superior anesthetic recovery.(AU)

A anestesia dissociativa em primatas resulta em recuperação anestésica lenta e estressante, e, portanto, o uso de anestesia injetável em pesquisas médicas precisa ser refinado. Por outro lado, o propofol promove recuperação mais suave. Os objetivos desse estudo foram investigar o uso do anestésico intravenoso propofol, estabelecer a taxa de infusão contínua necessária para manter anestesia cirúrgica, e comparar tal técnica com a dissociativa tiletamina-zolazepam em Sapajus apella. Oito macacos-prego saudáveis foram pré-medicados com midazolam e meperidina, e posteriormente anestesiados com propofol (PRO) ou tiletamina-zolazepam (TZ) durante 60 minutos. O propofol foi administrado em infusão contínua, e a taxa foi titulada ao efeito, já a tiletamina-zolazepam foi administrada em 5mg/kg IV como bolus inicial, e repiques de 2,5mg/kg IV conforme necessário. Os parâmetros cardiopulmonares, hemogasometria arterial, cortisol, e lactato, além da qualidade e duração da recuperação anestésica foram determinados. A qualidade da recuperação anestésica foi superior em PRO. O tempo para atingir decúbito ventral (PRO = 43,0±21,4 vs TZ = 219,3±139,7 min) e ambulação normal (PRO = 93±27,1 vs TZ = 493,7±47,8 min) foram mais rápidos em PRO (p<0,05). As variáveis cardiopulmonares não diferiram entre os grupos. A mediana para dose de indução com propofol foi de 5,9mg/kg, variando de 4,7 a 6,7mg/kg. A taxa de infusão contínua média de propofol foi de 0,37±0,11mg/kg/min, variando ao longo dos 60 minutos. Em TZ, dois animais necessitaram de três e cinco repiques. Comparado à tiletamina-zolazepam, menos efeitos adversos pós-anestésicos devem ser esperados com o propofol, devido à recuperação mais suave e rápida.(AU)

Assuntos

RESUMO

Dissociative anesthesia results in stressful and long recovery periods in monkeys and use of injectable anesthetics in medical research has to be refined. Propofol has promoted more pleasure wake up from anesthesia. The objectives of this study were to investigate the use of intravenous anesthetic propofol, establishing the required infusion rate to maintain surgical anesthetic level and comparing it to tiletamine-zolazepam anesthesia in Sapajus apella. Eight healthy capuchin monkeys, premedicated with midazolam and meperidine, were anesthetized with propofol (PRO) or tiletamine-zolazepam (TZ) during 60 minutes. Propofol was infused continually and rate was titrated to effect and tiletamine-zolazepam was given at 5mg/kg IV bolus initially and repeated at 2.5mg/kg IV bolus as required. Cardiopulmonary parameters, arterial blood gases, cortisol, lactate and quality and times to recovery were determined. Recovery quality was superior in PRO. Ventral recumbency (PRO = 43.0±21.4 vs TZ = 219.3±139.7 min) and normal ambulation (PRO = 93±27.1 vs TZ = 493.7±47.8 min) were faster in PRO (p<0.05). Cardiopulmonary effects did not have marked differences between groups. Median for induction doses of propofol was 5.9mg/kg, varying from 4.7 to 6.7mg/kg, Mean infusion rate was 0.37±0.11mg/kg/min, varying during the one-hour period. In TZ, two animals required three and five extra doses. Compared to tiletamine-zolazepam, minor post-anesthetic adverse events should be expected with propofol anesthesia due to the faster and superior anesthetic recovery. (AU)

A anestesia dissociativa em primatas resulta em recuperação anestésica lenta e estressante, e, portanto, o uso de anestesia injetável em pesquisas médicas precisa ser refinado. Por outro lado, o propofol promove recuperação mais suave. Os objetivos desse estudo foram investigar o uso do anestésico intravenoso propofol, estabelecer a taxa de infusão contínua necessária para manter anestesia cirúrgica, e comparar tal técnica com a dissociativa tiletamina-zolazepam em Sapajus apella. Oito macacos-prego saudáveis foram pré-medicados com midazolam e meperidina, e posteriormente anestesiados com propofol (PRO) ou tiletamina-zolazepam (TZ) durante 60 minutos. O propofol foi administrado em infusão contínua, e a taxa foi titulada ao efeito, já a tiletamina-zolazepam foi administrada em 5mg/kg IV como bolus inicial, e repiques de 2,5mg/kg IV conforme necessário. Os parâmetros cardiopulmonares, hemogasometria arterial, cortisol, e lactato, além da qualidade e duração da recuperação anestésica foram determinados. A qualidade da recuperação anestésica foi superior em PRO. O tempo para atingir decúbito ventral (PRO = 43,0±21,4 vs TZ = 219,3±139,7 min) e ambulação normal (PRO = 93±27,1 vs TZ = 493,7±47,8 min) foram mais rápidos em PRO (p<0,05). As variáveis cardiopulmonares não diferiram entre os grupos. A mediana para dose de indução com propofol foi de 5,9mg/kg, variando de 4,7 a 6,7mg/kg. A taxa de infusão contínua média de propofol foi de 0,37±0,11mg/kg/min, variando ao longo dos 60 minutos. Em TZ, dois animais necessitaram de três e cinco repiques. Comparado à tiletamina-zolazepam, menos efeitos adversos pós-anestésicos devem ser esperados com o propofol, devido à recuperação mais suave e rápida.(AU)

Assuntos

RESUMO

The objective of this study was to evaluate the quality and recovery from anesthesia promoted by the tiletamine-zolazepam (TZ) combination administered intravenously (IV) continuously in bitches pre-medicated with acepromazine. Eight cross-bred, clinically healthy bitches weighing 13.7 ±1.9kg on average were used in this study. After a food fast of 12 h and a water fast of four hours, the animals were treated with acepromazine (0.1mg/kg, intramuscular) and, after 15 minutes, anesthesia was induced with a combination of tiletamine-zolazepam (2mg/kg, IV) immediately followed by continuous IV infusion thereof at a dose of 2mg/kg/h for 60 min. The following parameters were measured in all animals immediately before administration of acepromazine (M15), immediately before anesthetic induction (M0), and at 5, 10, 20, 30, 40, 50, and 60 min after initiation of continuous infusion (M5, M10, M20, M30, M40, M50, and M60): electrocardiography (ECG), heart rate (HR), mean arterial pressure (MAP), respiratory rate (RR), body temperature (BT), and arterial hemogasometry, with the last performed only at experimental times M15, M0, M30, and M60. A subcutaneous electrical stimulator was used to evaluate the degree of analgesia. Myorelaxation and quality of anesthetic recovery were also assessed, classifying these parameters as excellent, good, and poor. Anesthetic recovery time was recorded in minutes. HR increased significantly at time M10 in relation to that at M-15, and at times M5, M10, M40, and M50 in relation to that at M0. MAP decreased significantly at M20 and M30 compared with the baseline. BT decreased significantly at M50 compared with that at M0, but no hypothermia was observed. RR showed significant reduction at M5, M10, and M20 in relation to that at M-15, and at M5 and M10 in relation to that at M0, and bradypnoea was observed during the first 20 min after anesthetic induction...(AU)

Objetivou-se avaliar a qualidade e a recuperação da anestesia promovida pela associação tiletamina-zolazepam, administrada por via intravenosa (IV) contínua, em cadelas pré-medicadas com acepromazina. Foram utilizadas oito cadelas, sem raças definidas, clinicamente sadias, pesando em média 13,7±1,9kg. Após jejum alimentar de 12 horas e hídrico de quatro horas, os animais foram medicados com acepromazina (0,1mg/kg, via intramuscular) e, após 15 minutos, a anestesia foi induzida com a associação tiletamina-zolazepam (2mg/kg, IV) seguida imediatamente pela infusão IV contínua da mesma, na dose de 2mg/kg/h, durante 60 minutos. Os parâmetros que foram mensurados em todos os animais, imediatamente antes da administração da acepromazina (M-15), imediatamente antes da indução anestésica (M0) e, aos 5, 10, 20, 30, 40, 50 e 60 minutos após o início da infusão contínua (M5, M10, M20, M30, M40, M50 e M60) foram os seguintes: eletrocardiografia (ECG), frequência cardíaca (FC), pressão arterial média (PAM), frequência respiratória (f), temperatura corpórea (TC) e hemogasometria arterial, esta sendo realizada apenas nos momentos M-15, M0, M30 e M60. Para avaliação do grau de analgesia foi empregado um estimulador elétrico subcutâneo. Também se avaliou o miorrelaxamento e a qualidade da recuperação anestésica, classificando estes parâmetros em: excelente, bom e ruim. O tempo de recuperação anestésica foi registrado em minutos. A FC aumentou significativamente no momento M10 em relação ao M-15, e nos momentos M5, M10, M40 e M50 em relação ao M0. A PAM diminuiu significativamente em M20 e M30 em comparação ao valor basal. A TC diminuiu significativamente em M50 em comparação ao M0, mas não foi observada hipotermia. A f apresentou uma redução significativa nos momentos M5, M10 e M20 em relação ao M-15, e em M5 e M10 em relação ao M0, sendo observado bradipneia durante os primeiros 20 minutos após a indução anestésica...(AU)

Assuntos

RESUMO

The objective of this study was to evaluate the quality and recovery from anesthesia promoted by the tiletamine-zolazepam (TZ) combination administered intravenously (IV) continuously in bitches pre-medicated with acepromazine. Eight cross-bred, clinically healthy bitches weighing 13.7 ±1.9kg on average were used in this study. After a food fast of 12 h and a water fast of four hours, the animals were treated with acepromazine (0.1mg/kg, intramuscular) and, after 15 minutes, anesthesia was induced with a combination of tiletamine-zolazepam (2mg/kg, IV) immediately followed by continuous IV infusion thereof at a dose of 2mg/kg/h for 60 min. The following parameters were measured in all animals immediately before administration of acepromazine (M15), immediately before anesthetic induction (M0), and at 5, 10, 20, 30, 40, 50, and 60 min after initiation of continuous infusion (M5, M10, M20, M30, M40, M50, and M60): electrocardiography (ECG), heart rate (HR), mean arterial pressure (MAP), respiratory rate (RR), body temperature (BT), and arterial hemogasometry, with the last performed only at experimental times M15, M0, M30, and M60. A subcutaneous electrical stimulator was used to evaluate the degree of analgesia. Myorelaxation and quality of anesthetic recovery were also assessed, classifying these parameters as excellent, good, and poor. Anesthetic recovery time was recorded in minutes. HR increased significantly at time M10 in relation to that at M-15, and at times M5, M10, M40, and M50 in relation to that at M0. MAP decreased significantly at M20 and M30 compared with the baseline. BT decreased significantly at M50 compared with that at M0, but no hypothermia was observed. RR showed significant reduction at M5, M10, and M20 in relation to that at M-15, and at M5 and M10 in relation to that at M0, and bradypnoea was observed during the first 20 min after anesthetic induction. Significant decreases in the PR interval at times M10, M40, and M50 were observed in relation to that at M15. Amplitude of the R wave showed significant decrease at M20 compared with that at M-15. In the other ECG parameters, no significant difference was observed between the times evaluated. Hemogasometric parameters and analgesia did not show significant alterations. Myorelaxation and quality of anesthetic recovery were considered excellent. Recovery time was 15.1±7.7 min for positioning of sternal decubitus and 45.5±23.1 minutes for return of ambulation. Continuous IV administration of TZ combination does not produce satisfactory analgesia and does not cause severe cardiorespiratory and hemogasometric effects in bitches pre-medicated with acepromazine.(AU)

Objetivou-se avaliar a qualidade e a recuperação da anestesia promovida pela associação tiletamina-zolazepam, administrada por via intravenosa (IV) contínua, em cadelas pré-medicadas com acepromazina. Foram utilizadas oito cadelas, sem raças definidas, clinicamente sadias, pesando em média 13,7±1,9kg. Após jejum alimentar de 12 horas e hídrico de quatro horas, os animais foram medicados com acepromazina (0,1mg/kg, via intramuscular) e, após 15 minutos, a anestesia foi induzida com a associação tiletamina-zolazepam (2mg/kg, IV) seguida imediatamente pela infusão IV contínua da mesma, na dose de 2mg/kg/h, durante 60 minutos. Os parâmetros que foram mensurados em todos os animais, imediatamente antes da administração da acepromazina (M-15), imediatamente antes da indução anestésica (M0) e, aos 5, 10, 20, 30, 40, 50 e 60 minutos após o início da infusão contínua (M5, M10, M20, M30, M40, M50 e M60) foram os seguintes: eletrocardiografia (ECG), frequência cardíaca (FC), pressão arterial média (PAM), frequência respiratória (f), temperatura corpórea (TC) e hemogasometria arterial, esta sendo realizada apenas nos momentos M-15, M0, M30 e M60. Para avaliação do grau de analgesia foi empregado um estimulador elétrico subcutâneo. Também se avaliou o miorrelaxamento e a qualidade da recuperação anestésica, classificando estes parâmetros em: excelente, bom e ruim. O tempo de recuperação anestésica foi registrado em minutos. A FC aumentou significativamente no momento M10 em relação ao M-15, e nos momentos M5, M10, M40 e M50 em relação ao M0. A PAM diminuiu significativamente em M20 e M30 em comparação ao valor basal. A TC diminuiu significativamente em M50 em comparação ao M0, mas não foi observada hipotermia. A f apresentou uma redução significativa nos momentos M5, M10 e M20 em relação ao M-15, e em M5 e M10 em relação ao M0, sendo observado bradipneia durante os primeiros 20 minutos após a indução anestésica. Foram observadas diminuições significativas do intervalo PR nos momentos M10, M40 e M50, em relação ao M-15. A amplitude da onda R apresentou diminuição significativa em M20 em comparação ao M-15. Nos demais parâmetros da ECG não houve diferença significativa entre os momentos avaliados. Os parâmetros hemogasométricos e a analgesia não apresentaram alterações significativas. O miorrelaxamento e a qualidade da recuperação anestésica foram considerados excelentes. O período de recuperação foi de 15,1±7,7 minutos para posicionamento do decúbito esternal e 45,5±23,1 minutos para retorno da deambulação. A administração intravenosa contínua de tiletamina-zolazepam não produz analgesia satisfatória e não causa efeitos cardiorrespiratórios e hemogasométricos severos, em cadelas pré-tratadas com acepromazina.(AU)

Assuntos

RESUMO

OBJECTIVE: To evaluate the effect of hyaluronidase on uptake, duration and speed of elimination of xylazine-tiletamine-zolazepam administered in the subcutaneous fat over the dorsal lumbar region of swine. STUDY DESIGN: Blinded, randomized, crossover study. ANIMALS: Six healthy Landrace/Large White pigs weighing 132±24 kg (mean±standard deviation). METHODS: Animals were administered xylazine (1 mg kg-1) and tiletamine-zolazepam (8 mg kg-1) (control treatment, CON), or xylazine-tiletamine-zolazepam at the same doses with hyaluronidase (400 IU) (treatment HYA). The treatments were administered into the dorsal lumbar adipose tissue, 2.5-3.0 cm laterally from the spinous process of the second lumbar vertebra. The latency, anesthesia and recovery periods were measured. Heart rate, noninvasive systolic, diastolic, and mean arterial pressures, respiratory rate, hemoglobin oxygen saturation and rectal temperature were recorded every 10 minutes for up to 50 minutes. RESULTS: One animal in CON and one animal in HYA were responsive to stimulation and did not allow safe handling. No significant difference was found between treatments for latency (CON 11.3±5.9 minutes, HYA 7.4±5.1 minutes) and anesthesia (CON 53±53 minutes, HYA 49±38 minutes) periods. Recovery period was shorter in HYA (9±6 minutes) than in CON (32±16 minutes) (p < 0.05). Physiological variables were not significantly changed over time and were within accepted normal clinical limits for the species in both treatments. CONCLUSION AND CLINICAL RELEVANCE: Hyaluronidase (400 IU) administered into adipose tissue in pigs did not reduce the latency and duration of dissociative anesthesia, but was associated with faster recovery.

Assuntos

RESUMO

We describe the use of a combination of tiletamine and zolazepam (Zoletil®) for chemical restraint of South American coatis ( Nasua nasua ) under field conditions. We immobilized 53 coatis from a free-ranging population at Iguaçu National Park, Brazil, with Zoletil. Males and females (1.0-8.7 kg) of different age groups participated in the study. Four dosage (milligram per kilogram body weight) groups were created based on quartiles as follows: 1) 4.76-6.68 mg/kg (n=13), 2) 6.83-7.71 mg/kg (n=13), 3) 7.72-8.68 mg/kg (n=18), and 4) 8.98-11.57 mg/kg (n=9). Variables analyzed were sex, age, body weight, dosage, induction time, handling time (HT: time elapsed between the onset of immobilization and first signs of recovery), time from injection to first stand-up posture after anesthesia, heart and respiratory rates, and body temperature. Mean (±SD) induction time was 2.9 (±1.4) min and was positively correlated with age. In dosage groups 1-4, mean HTs were 40.3 (±24.0), 64.5 (±19.1), 54.8 (±15.0), and 60.3 (±12.0), respectively. Handling time had a positive linear relationship with age and body weight, but the relationship between HT and dosage was nonlinear. Group 1 had a shorter HT compared to the other groups combined. Time from injection to first stand-up was 105.0 (±33.5) min. Zoletil was quick acting and safe for immobilization of coatis in the wild.

Assuntos

RESUMO

O presente estudo tem como objetivo avaliar o efeito da administração do Zolazepam/Tiletamina nas funções cardiorrespiratórias e eletrocardiográficas em lobos-guará (Chrysocyon brachyurus) mantidos em cativeiro. Foram utilizados dez lobos-guará clinicamente saudáveis (seis machos e quatro fêmeas), com média de peso 23,5±3,5kg, e idade de 6,5±2,8 anos. Os lobos eram mantidos em cativeiro e foram capturados pelos tratadores, proporcionando o mínimo de estresse possível para avaliação dos parâmetros pré-anestésicos. Foram avaliadas frequência cardíaca e respiratória, temperatura retal, pressão arterial média e eletrocardiografia. Após coleta dos parâmetros fisiológicos e eletrocardiográficos pré-anestesia, foi administrada a dose de 5,1±0,7mg/kg de Zolazepam/Tiletamina intramuscular. Depois da anestesia, colocaram-se os eletrodos do eletrocardiograma nos membros torácicos e pélvicos. Os animais eram monitorados durante uma hora, sendo que, a cada 10 minutos, era realizado o registro dos valores eletrocardiográficos, assim como os valores dos parâmetros fisiológicos e cardiorrespiratórios. Os resultados mostraram alteração significativa na amplitude da onda P entre 10 a 50 minutos pós-anestesia. Frequência cardíaca (153±20bmp), frequência respiratória (29±6mpm), temperatura corporal (38,4±1oC), pressão arterial média (114±20mmHg) e as outras variáveis eletrocardiográficas não apresentaram alterações. O aumento da amplitude da onda P nos animais deste trabalho sugeriu um aumento atrial, oriundo de doenças cardíacas ou simplesmente pelo aumento da frequência cardíaca durante a contenção(AU)

The aim of this study was to assess the effects of the anesthetic combination of Tiletamine/Zolazepam on the cardiorespiratory function and electrocardiographic profile in captive maned wolves (Chrysocyon brachyurus). Ten maned wolves were used in this study (6 males and 4 females). All animals were healthy, with an average body weight of 23.5±3.5kg, and age of 6.5±2.8years. The wolves were conditioned to be physically restrained by their keepers in order to minimize stress during assessment of pre-anesthetic parameters. Data on heart and respiratory rates, rectal temperature, mean arterial blood pressure and electrocardiography were collected. Pre-anesthetic physiological an eletrocardiographic parameters were collected before the administration of 5.1±0.73mg/kg Tiletamine/Zolazepam intramuscularly. Under anesthesia, electrocardiogram electrodes were placed on thoracic and pelvic limbs and eletrocardiographic data was recorded every 10 minutes for approximately one hour, totaling 6 electrocardiograms. Heart rate 153±20bmp, respiratory rate 29±6mpm, rectal temperature 38,4±1oC, mean arterial blood pressure 114±20mmHg, and the other electrocardiographic parameters did not change; however, the P wave amplitude changed from 10 to 50 minutes after anesthesia. The increase in the P wave on the animals in this study suggested an atrial increase, probably due to cardiac disease or just by increasing the heart rate during the capture(AU)

Assuntos

RESUMO

O presente estudo tem como objetivo avaliar o efeito da administração do Zolazepam/Tiletamina nas funções cardiorrespiratórias e eletrocardiográficas em lobos-guará (Chrysocyon brachyurus) mantidos em cativeiro. Foram utilizados dez lobos-guará clinicamente saudáveis (seis machos e quatro fêmeas), com média de peso 23,5±3,5kg, e idade de 6,5±2,8 anos. Os lobos eram mantidos em cativeiro e foram capturados pelos tratadores, proporcionando o mínimo de estresse possível para avaliação dos parâmetros pré-anestésicos. Foram avaliadas frequência cardíaca e respiratória, temperatura retal, pressão arterial média e eletrocardiografia. Após coleta dos parâmetros fisiológicos e eletrocardiográficos pré-anestesia, foi administrada a dose de 5,1±0,7mg/kg de Zolazepam/Tiletamina intramuscular. Depois da anestesia, colocaram-se os eletrodos do eletrocardiograma nos membros torácicos e pélvicos. Os animais eram monitorados durante uma hora, sendo que, a cada 10 minutos, era realizado o registro dos valores eletrocardiográficos, assim como os valores dos parâmetros fisiológicos e cardiorrespiratórios. Os resultados mostraram alteração significativa na amplitude da onda P entre 10 a 50 minutos pós-anestesia. Frequência cardíaca (153±20bmp), frequência respiratória (29±6mpm), temperatura corporal (38,4±1oC), pressão arterial média (114±20mmHg) e as outras variáveis eletrocardiográficas não apresentaram alterações. O aumento da amplitude da onda P nos animais deste trabalho sugeriu um aumento atrial, oriundo de doenças cardíacas ou simplesmente pelo aumento da frequência cardíaca durante a contenção.

The aim of this study was to assess the effects of the anesthetic combination of Tiletamine/Zolazepam on the cardiorespiratory function and electrocardiographic profile in captive maned wolves (Chrysocyon brachyurus). Ten maned wolves were used in this study (6 males and 4 females). All animals were healthy, with an average body weight of 23.5±3.5kg, and age of 6.5±2.8years. The wolves were conditioned to be physically restrained by their keepers in order to minimize stress during assessment of pre-anesthetic parameters. Data on heart and respiratory rates, rectal temperature, mean arterial blood pressure and electrocardiography were collected. Pre-anesthetic physiological an eletrocardiographic parameters were collected before the administration of 5.1±0.73mg/kg Tiletamine/Zolazepam intramuscularly. Under anesthesia, electrocardiogram electrodes were placed on thoracic and pelvic limbs and eletrocardiographic data was recorded every 10 minutes for approximately one hour, totaling 6 electrocardiograms. Heart rate 153±20bmp, respiratory rate 29±6mpm, rectal temperature 38,4±1oC, mean arterial blood pressure 114±20mmHg, and the other electrocardiographic parameters did not change; however, the P wave amplitude changed from 10 to 50 minutes after anesthesia. The increase in the P wave on the animals in this study suggested an atrial increase, probably due to cardiac disease or just by increasing the heart rate during the capture.

Assuntos

RESUMO

BACKGROUND: Dissociative drugs are used for chemical restraint in monkeys. The aim was to evaluate muscle relaxation, recovery, and ophthalmic and hemodynamic parameters in 24 capuchin monkeys subjected to four dissociative anesthesia protocols. METHODS: Animals were anesthetized with tiletamine-zolazepam (TZ), ketamine-xylazine (KX), ketamine-midazolam (KM), or ketamine-dexmedetomidine (KD). Muscle relaxation, digital reflex, lacrimal production, intraocular pressure (IOP), heart and respiratory rates, oxygen saturation (SpO2 ), rectal temperature, non-invasive arterial blood pressure, palpebral and pupillary reflexes, and eyeball positioning were evaluated every 5 minutes for 20 minutes. RESULTS: Muscle relaxation was highest in KM and KD. At 5-minute post-injection, IOP was higher in TZ than in all other groups. There was a significant difference between groups and times in heart and respiratory rates and temperature. There were no significant differences in SpO2, arterial blood pressure, and lacrimal production between groups. CONCLUSIONS: The established parameters may help in clinical and ophthalmic examinations of primates.

Assuntos

RESUMO

O objetivo do presente estudo foi o de avaliar os efeitos das associações anestésicas cetaminamidazolam, cetamina-xilazina e tiletamina-zolazepam sobre a PIO em coelhos. Em estudo do tipo prospectivo, experimental, cego, cruzado e randomizado, foram utilizados seis coelhos distruibuídos aleatoriamente em três tratamentos, designados como grupos CM (cetamina 30 mg/kg + midazolam, 1 mg/kg), CX (cetamina, 30 mg/kg + xilazina, 3 mg/kg) e TZ (tiletamina + zolazepam, 20 mg/kg), associados na mesma seringa e aplicados por via intramuscular no músculo quadriceps femoral. A PIO foi mensurada previamente a administração dos fármacos (basal) e com 5 minutos de intervalo por um período de 30 minutos. Os dados foram comparados pela análise de variância (ANOVA) de amostras repetidas seguidas pelo teste de Bonferroni. Em todos os grupos foi verificado redução significativa da PIO comparativamente ao valor basal (p 0,001). Não foi observado diferença entre os grupos em nenhum momento (p > 0,05). A administração das associações cetamina-midazolam, cetamina-xilazina e tiletamina-zolazepam reduzem a PIO de maneira similar em coelhos em até 30 minutos da aplicação.(AU)

The aim of this study was evaluate the effects of three anesthetic combinations, ketamine-midazolam, ketamine-xylazine and tiletamine-zolazepam, on IOP in rabbits. In a experimental, blind, randomized, crossover study, six rabbits were anesthetized with each of 3 treatments in random order. Groups KM (ketamine, 30 mg/kg + midazolam, 1 mg/kg); KX (ketamine, 30 mg/kg + xylazine, 3 mg/kg); and TZ (tiletamine + zolazepam, 20 mg/kg). The drugs were mixed in the same syringe injected intramuscularly (IM) into the quadriceps muscle. IOP was measured before drug administration (baseline) and at 5-minute intervals for 30 minutes. The data were analyzed by a 2-way repeated measures ANOVA followed by Bonferroni test. All groups had significant decreases in IOP compared to baseline (p 0.001). There was no difference between groups at any of the time points assessed (p > 0.05). Administration of either ketamine-midazolam, ketamine-xylazine, or tiletamine-zolazepam similarly decrease IOP in rabbits within 30 minutes of injection.(AU)

Assuntos

RESUMO

Two protocols to immobilise free-ranging Pampas foxes for ear-tagging or radio-collaring were evaluated. One hundred fifteen foxes were injected with ketamine-xylazine (K-X) and thirteen with tiletamine-zolazepam (T-Z). The use of both T-Z and K-X combinations typically resulted in a smooth induction and recovery. In 86% of the cases K-X protocol was judged effective (mean±SD, K: 10.7±3.3mg/kg, X: 1.0±1.0mg/kg) while T-Z protocol was judged effective in 92% of the cases (T: 3.6±1.05mg/kg, Z: 3.6±1.05mg/kg). The primary differences between the two drug combinations were that the time necessary for the complete recovery was longer with T-Z, and thermic problems were found more frequently with K-X. Additionally, our results suggest that thermic stress may be a relatively frequent complication for Pampas foxes. This study provides baseline data on some physiologic variables in Pampas foxes captured with different methods and drugs in field conditions.

Assuntos

RESUMO

A associação da tiletamina ao zolazepam(T/Z) é utilizada como anestesiadissociativa (AD) em animais decompanhia, promovendo analgesiasomática de curta duração, perda dosmovimentos voluntários e miorelaxamentocausado pelo benzodiazepínico, comestimulação cardiovascular e manutençãodos reflexos protetores. Em virtude dagrande utilização da T/Z na castraçãoeletiva de felinos e suas característicasanestésicas, buscou-se monitorar eidentificar as possíveis alteraçõeseletrocardiográficas (ECG) e clínicasocorridas no período trans-anestésico,com ou sem o fornecimento daoxigênioterapia via máscara. Para isso,utilizaram-se 20 fêmeas felinas, SRD,adultas jovens, hígidas, previamenteavaliadas, por meio do exame clínico,laboratorial e eletrocardiográfico.Realizou-se a pré-medicação comtramadol e anestesia com T/Z. Os felinosforam divididos aleatoriamente, sendo ogrupo G1 (n=10) que receberamsuplementação com oxigênio FiO2 viamáscara durante o período transanestésico,e o grupo G2 (n=10) semsuplementação, com ambos monitoradospor meio da avaliação da frequênciacardíaca (FC), respiratória (FR), pressãoarterial sistólica (PAS), temperatura retal(T°C) e oximetria de pulso, com agravação dos traçados e derivações ECGde cada felino, que posteriormente foramavaliados e interpretados. As análisesdemonstraram diferenças significativasentre os grupos na FR (G1=26,8±2,1 e G2= 38,5±3,2) e oximetria de pulso(G1=97,3±2,4% e G2=91,2±1,1%), odesenvolvimento bloqueio de ramo direitode forma intermitente e osupradesnivelamento S-T em ambos osgrupos. Conclui-se então, que ascaracterísticas eletrocardiográficas foramidênticas nos grupos independente dasuplementação de oxigênio, porémmostrando melhora dos parâmetrosclínicos nos felinos suplementados comoxigênio via máscara.(AU)

The association of tiletamine withzolazepam (T/Z) is commonly used indissociative anesthesia in household pets.This combination induces short-durationsomatic analgesia, loss of voluntarymovements and myorelaxation caused bythe benzodiazepin, with stimulation of theardiovascular system and maintenance ofprotective reflexes. Due to the large use ofthis association in elective neutering offelines and its anesthetic properties, wechose to monitorize and identifyelectrocardiographic (ECG) and clinicalchanges during the anesthetic procedure,with and without oxygen supplementation.For this study, 20 female felines wererecruited. All animals were young adults,healthy, no specific breed. The subjectsunderwent clinical, laboratorial andelectrocardiographic evaluations prior toanesthesia. Tramadol hydrochloride wasgiven as Preanesthetic medicationfollowed by anesthesia with T/Z. Thefelines were randomly assigned to eitherGroup 1 (n=10), in which subjects receivedoxygen supplementation through maskduring the anesthetic procedure, or Group2 (n=10), in which subjects were notsupplemented with oxygen. Heart andrespiratory rates, systolic blood pressure, rectal temperature and pulse oxymetrywere monitored in all subjects from bothgroups. We also obtained recordings ofthe ECG tracing and derivations for eachanimal which were posteriorly evaluatedand interpreted. The results showedsignificant differences between the groupsin respiratory rate (G1 = 26,8 +/- 2,1 andG2= 38,5+/- 3,2) and pulse oxymetry (G1=97,3 +/- 2,4% and G2 = 91,2 +/- 1,1%).We also observed on the ECG recordingsdevelopment of periods of intermittent rightbranch blockage and S-T elevation in bothgroups. We therefore concluded that theECG recordings were identical in bothgroups despite oxygenotherapy; however,we observed an improvement in theclinical parameters in animals whoreceived oxygen supplementation viamask. (AU)

Assuntos

RESUMO

O objetivo do presente estudo foi o de avaliar os efeitos das associações anestésicas cetaminamidazolam, cetamina-xilazina e tiletamina-zolazepam sobre a PIO em coelhos. Em estudo do tipo prospectivo, experimental, cego, cruzado e randomizado, foram utilizados seis coelhos distruibuídos aleatoriamente em três tratamentos, designados como grupos CM (cetamina 30 mg/kg + midazolam, 1 mg/kg), CX (cetamina, 30 mg/kg + xilazina, 3 mg/kg) e TZ (tiletamina + zolazepam, 20 mg/kg), associados na mesma seringa e aplicados por via intramuscular no músculo quadriceps femoral. A PIO foi mensurada previamente a administração dos fármacos (basal) e com 5 minutos de intervalo por um período de 30 minutos. Os dados foram comparados pela análise de variância (ANOVA) de amostras repetidas seguidas pelo teste de Bonferroni. Em todos os grupos foi verificado redução significativa da PIO comparativamente ao valor basal (p 0,001). Não foi observado diferença entre os grupos em nenhum momento (p > 0,05). A administração das associações cetamina-midazolam, cetamina-xilazina e tiletamina-zolazepam reduzem a PIO de maneira similar em coelhos em até 30 minutos da aplicação.

The aim of this study was evaluate the effects of three anesthetic combinations, ketamine-midazolam, ketamine-xylazine and tiletamine-zolazepam, on IOP in rabbits. In a experimental, blind, randomized, crossover study, six rabbits were anesthetized with each of 3 treatments in random order. Groups KM (ketamine, 30 mg/kg + midazolam, 1 mg/kg); KX (ketamine, 30 mg/kg + xylazine, 3 mg/kg); and TZ (tiletamine + zolazepam, 20 mg/kg). The drugs were mixed in the same syringe injected intramuscularly (IM) into the quadriceps muscle. IOP was measured before drug administration (baseline) and at 5-minute intervals for 30 minutes. The data were analyzed by a 2-way repeated measures ANOVA followed by Bonferroni test. All groups had significant decreases in IOP compared to baseline (p 0.001). There was no difference between groups at any of the time points assessed (p > 0.05). Administration of either ketamine-midazolam, ketamine-xylazine, or tiletamine-zolazepam similarly decrease IOP in rabbits within 30 minutes of injection.

Assuntos

RESUMO

A associação da tiletamina ao zolazepam(T/Z) é utilizada como anestesiadissociativa (AD) em animais decompanhia, promovendo analgesiasomática de curta duração, perda dosmovimentos voluntários e miorelaxamentocausado pelo benzodiazepínico, comestimulação cardiovascular e manutençãodos reflexos protetores. Em virtude dagrande utilização da T/Z na castraçãoeletiva de felinos e suas característicasanestésicas, buscou-se monitorar eidentificar as possíveis alteraçõeseletrocardiográficas (ECG) e clínicasocorridas no período trans-anestésico,com ou sem o fornecimento daoxigênioterapia via máscara. Para isso,utilizaram-se 20 fêmeas felinas, SRD,adultas jovens, hígidas, previamenteavaliadas, por meio do exame clínico,laboratorial e eletrocardiográfico.Realizou-se a pré-medicação comtramadol e anestesia com T/Z. Os felinosforam divididos aleatoriamente, sendo ogrupo G1 (n=10) que receberamsuplementação com oxigênio FiO2 viamáscara durante o período transanestésico,e o grupo G2 (n=10) semsuplementação, com ambos monitoradospor meio da avaliação da frequênciacardíaca (FC), respiratória (FR), pressãoarterial sistólica (PAS), temperatura retal(T°C) e oximetria de pulso, com agravação dos traçados e derivações ECGde cada felino, que posteriormente foramavaliados e interpretados. As análisesdemonstraram diferenças significativasentre os grupos na FR (G1=26,8±2,1 e G2= 38,5±3,2) e oximetria de pulso(G1=97,3±2,4% e G2=91,2±1,1%), odesenvolvimento bloqueio de ramo direitode forma intermitente e osupradesnivelamento S-T em ambos osgrupos. Conclui-se então, que ascaracterísticas eletrocardiográficas foramidênticas nos grupos independente dasuplementação de oxigênio, porémmostrando melhora dos parâmetrosclínicos nos felinos suplementados comoxigênio via máscara.

The association of tiletamine withzolazepam (T/Z) is commonly used indissociative anesthesia in household pets.This combination induces short-durationsomatic analgesia, loss of voluntarymovements and myorelaxation caused bythe benzodiazepin, with stimulation of theardiovascular system and maintenance ofprotective reflexes. Due to the large use ofthis association in elective neutering offelines and its anesthetic properties, wechose to monitorize and identifyelectrocardiographic (ECG) and clinicalchanges during the anesthetic procedure,with and without oxygen supplementation.For this study, 20 female felines wererecruited. All animals were young adults,healthy, no specific breed. The subjectsunderwent clinical, laboratorial andelectrocardiographic evaluations prior toanesthesia. Tramadol hydrochloride wasgiven as Preanesthetic medicationfollowed by anesthesia with T/Z. Thefelines were randomly assigned to eitherGroup 1 (n=10), in which subjects receivedoxygen supplementation through maskduring the anesthetic procedure, or Group2 (n=10), in which subjects were notsupplemented with oxygen. Heart andrespiratory rates, systolic blood pressure, rectal temperature and pulse oxymetrywere monitored in all subjects from bothgroups. We also obtained recordings ofthe ECG tracing and derivations for eachanimal which were posteriorly evaluatedand interpreted. The results showedsignificant differences between the groupsin respiratory rate (G1 = 26,8 +/- 2,1 andG2= 38,5+/- 3,2) and pulse oxymetry (G1=97,3 +/- 2,4% and G2 = 91,2 +/- 1,1%).We also observed on the ECG recordingsdevelopment of periods of intermittent rightbranch blockage and S-T elevation in bothgroups. We therefore concluded that theECG recordings were identical in bothgroups despite oxygenotherapy; however,we observed an improvement in theclinical parameters in animals whoreceived oxygen supplementation viamask.

Assuntos

RESUMO

Dez cães receberam administração epidural da associação de cloridrato de tiletamina e zolazepam, entre as vértebras L7 e S1, avaliando-se a analgesia pela observação dos padrões respiratório e comportamental, e pela aplicação dos filamentos de von Frey nos coxins plantares e ao redor do esfíncter anal externo. Não foram observadas as manifestações sistêmicas características da administração parenteral de anestésicos dissociativos, e todos os animais manifestaram completa analgesia, sendo que o emprego dos filamentos de von Frey permitiu testes de sensibilidade cutânea sem causar lesões teciduais. A técnica empregada promoveu ataxia e paresia, que perduraram por 41,25 (± 2,18) minutos, acompanhadas por relaxamento do esfíncter anal externo dos cães. Outros estudos sobre os efeitos da administração epidural da associação de cloridrato de tiletamina e zolazepam deverão ser efetuados, no que diz respeito a quantificar e qualificar a analgesia nesse período, bem como avaliar a possibilidade de realização de intervenções cirúrgicas cruentas, com essa técnica.

Ten dogs received an epidural administration of tiletamine HCl and zolazepam, between vertebrae L7 and S1. The analgesia was evaluated by observation breathing and behavioral patterns, and by the use of von Frey filaments applied to the external anal sphincter and footpads. Systemic manifestations from parenteral administration of dissociative anesthetics were not observed, and all the animals showed complete analgesia. The technique promoted ataxia and paresis which persisted for 41.25 (±2.18) minutes, followed by external anal sphincter myorelaxation. The von Frey filaments allowed cutaneous sensibility tests without causing any tissue lesion. Other investigations searching the tiletamine HCL and zolazepam effects should be performed in order to quantify and qualify the analgesia in that period, as well as to evaluate the possibility of accomplishment of painful surgical procedures with this technique.

Diez perros recibieron administración epidural de la asociación de clorhidrato de tiletamina y zolazepam, entre las vértebras L7 y S1, evaluándose la analgesia por observación de los estándares respiratorio y de comportamiento, y por la aplicación de los filamentos de von Frey en los asientos plantares y alrededor del esfínter anal externo. No fueron observadas las manifestaciones sistémicas características de la administración parenteral de anestésicos disociativos, y todos los animales manifestaron completa analgesia, siendo que el empleo de filamentos de von Frey permitió testes de sensibilidad cutánea sin causar lesiones en tejidos. La técnica empleada promovió ataxia y paresia, que perduraron por 41,25 (±2,18) minutos, acompañadas por relajamiento del esfínter anal externo de los perros. Otros estudios sobre los efectos de la administración epidural de la asociación de clorhidrato de tiletamina y zolazepam deberán ser efectuados, por lo que respecta a cuantificar y calificar la analgesia en ese período, bien como evaluar la posibilidad de realización de procedimientos quirúrgicos cruentos, con esa técnica.

Assuntos

RESUMO

The effect of butorphanol was investigated in six adult cats anesthetized with romifidine-tiletamine-zolazepam. Cats were given romifidine (40µg.kg-1) tiletamine (7mg.kg-1) and zolazepam (7mg.kg-1) (RTZ) intramuscularly, or RTZ and butorphanol (0.2mg.kg-1) (RTZB). Heart rate, respiratory rate, oscillometric systolic blood pressure, diastolic blood pressure and mean blood pressure, oxihemoglobin saturation and rectal temperature were determined for 120 minutes and compared to baseline values. Anesthetic effects were evaluated using a score system. Time of induction, anesthesia and recovery were also determined for comparison. Induction time and anesthetic time were significantly longer in RTZB. In the RTZB group a significant decrease in respiratory rate was observed while in the RTZ group this was transitory. Heart rate did not change in the RTZ group until 60 minutes and decreased significantly in the RTZB group from the time of injection. It is concluded that RTZ is an effective anesthetic combination with minimal cardiovascular side effects and that addition of butorphanol to this combination prolongs the anesthetic time and induces analgesia for a longer period, but causes a decrease in heart and respiratory rate in cats.

Visando observar os efeitos do butorfanol (B) na anestesia produzida pela associação de romifidina (R) e tiletamina-zolazepam (TZ), foram utilizados seis gatos adultos, de forma que todos animais receberam a associação de romifidina-tiletamina-zolazepam (grupo RTZ) ou a associação de romifidina-tiletamina-zolazepam-butorfanol (grupo RTZB). Os animais receberam em aplicação única, por via intramuscular, 7mg.kg-1 de tiletamina e 7mg.kg-1 de zolazepam e 40µg.kg-1 de romifidina (grupo RTZ) ou a mesma associação acrescida de 0,2mg.kg-1 de B (grupo RTZB). A freqüência cardíaca, freqüência respiratória, pressão arterial sistólica, diastólica e média por método não-invasivo oscilométrico, saturação de oxihemoglobina e temperatura retal foram avaliadas durante 120 minutos e comparadas aos valores basais. Os efeitos anestésicos foram caracterizados por meio de um sistema de escores. Outros dados como período de latência, período anestésico hábil e período de recuperação foram mensurados para efeito comparativo. Os períodos de latência e anestésico hábil foram significativamente mais prolongados no grupo RTZB. Ocorreu diminuição da freqüência respiratória no grupo RTZB, havendo decréscimo transitório no grupo RTZ. A freqüência cardíaca não variou no grupo RTZ até os 60 minutos e decresceu significativamente no grupo RTZB. Conclui-se que a associação RTZ produz anestesia com mínimos efeitos cardiovasculares e que a adição do butorfanol à associação prolonga o tempo anestésico hábil, além de proporcionar analgesia mais duradoura, mas provoca efeitos colaterais como decréscimo da freqüência cardíaca e da freqüência respiratória em gatos.

RESUMO

The effect of butorphanol was investigated in six adult cats anesthetized with romifidine-tiletamine-zolazepam. Cats were given romifidine (40µg.kg-1) tiletamine (7mg.kg-1) and zolazepam (7mg.kg-1) (RTZ) intramuscularly, or RTZ and butorphanol (0.2mg.kg-1) (RTZB). Heart rate, respiratory rate, oscillometric systolic blood pressure, diastolic blood pressure and mean blood pressure, oxihemoglobin saturation and rectal temperature were determined for 120 minutes and compared to baseline values. Anesthetic effects were evaluated using a score system. Time of induction, anesthesia and recovery were also determined for comparison. Induction time and anesthetic time were significantly longer in RTZB. In the RTZB group a significant decrease in respiratory rate was observed while in the RTZ group this was transitory. Heart rate did not change in the RTZ group until 60 minutes and decreased significantly in the RTZB group from the time of injection. It is concluded that RTZ is an effective anesthetic combination with minimal cardiovascular side effects and that addition of butorphanol to this combination prolongs the anesthetic time and induces analgesia for a longer period, but causes a decrease in heart and respiratory rate in cats.

Visando observar os efeitos do butorfanol (B) na anestesia produzida pela associação de romifidina (R) e tiletamina-zolazepam (TZ), foram utilizados seis gatos adultos, de forma que todos animais receberam a associação de romifidina-tiletamina-zolazepam (grupo RTZ) ou a associação de romifidina-tiletamina-zolazepam-butorfanol (grupo RTZB). Os animais receberam em aplicação única, por via intramuscular, 7mg.kg-1 de tiletamina e 7mg.kg-1 de zolazepam e 40µg.kg-1 de romifidina (grupo RTZ) ou a mesma associação acrescida de 0,2mg.kg-1 de B (grupo RTZB). A freqüência cardíaca, freqüência respiratória, pressão arterial sistólica, diastólica e média por método não-invasivo oscilométrico, saturação de oxihemoglobina e temperatura retal foram avaliadas durante 120 minutos e comparadas aos valores basais. Os efeitos anestésicos foram caracterizados por meio de um sistema de escores. Outros dados como período de latência, período anestésico hábil e período de recuperação foram mensurados para efeito comparativo. Os períodos de latência e anestésico hábil foram significativamente mais prolongados no grupo RTZB. Ocorreu diminuição da freqüência respiratória no grupo RTZB, havendo decréscimo transitório no grupo RTZ. A freqüência cardíaca não variou no grupo RTZ até os 60 minutos e decresceu significativamente no grupo RTZB. Conclui-se que a associação RTZ produz anestesia com mínimos efeitos cardiovasculares e que a adição do butorfanol à associação prolonga o tempo anestésico hábil, além de proporcionar analgesia mais duradoura, mas provoca efeitos colaterais como decréscimo da freqüência cardíaca e da freqüência respiratória em gatos.